Lenalidomide,bortezomib,dexamethasone 
Takeda
['multiple myeloma', 'determination', 'triplet']
determination: among adults with multiple myeloma, continuous lenalidomide maintenance therapy after triplet therapy (rvd, plus asct) associated with longer pfs than triplet therapy alone. #asco22 
The New England Journal of Medicine (https://t.co/YGfDrRsIhE) is the world’s leading medical journal and website.